Joshua Field
Section Head · Medical College of Wisconsin Affiliated Hospitals, Inc
Credentials: · · · · ·
History
2004–2007
Research
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
Blood Advances · 2020 · 385 citations
Arteriosclerosis · 2010 · 161 citations
Blood · 2009 · 125 citations
25 papers
21 papers
- RS
16 papers
10 papers
8 papers
7 papers
7 papers
6 papers
Grants
- 2013–2018
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
Food and Drug Administration · R01
PI · $1.6M · Vanderbilt University Medical Center
- 2012–2018
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
National Heart, Lung, and Blood Institute · P50
PI · $10.8M · Dana-Farber Cancer Inst
- 2012–2017
Biomarkers of Inflammation and Vaso-Occlusion in Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
PI · $4M · la Jolla Institute for Immunology
- 2011–2014
A Feasibility Study of Regadenoson for the Treatment of Acute Chest Syndrome
National Heart, Lung, and Blood Institute · R34
PI · $682.1K · Dana-Farber Cancer Inst
Clinical trials
- 2013–2018
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
Principal investigator · Completed · Phase 2
Vanderbilt University Medical Center
- 2012–2020
Microvascular Blood Flow in Sickle Cell Anemia
Principal investigator · Completed
Versiti Blood Health